Skip to content
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
KeyPediaKeyPedia
  • Company
  • Platform
  • Media
  • KeyPedia Lite
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Joseph L. Lillo, D.O.
FDA Inspection•Joseph L. Lillo, D.O.•April 17, 2017

Joseph L. Lillo, D.O. – FDA Inspection, Apr 17, 2017

Record Details

This FDA Inspection record concerns Joseph L. Lillo, D.O., with an inspection on April 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Joseph L. Lillo, D.O.
Inspection Date
April 17, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Michelle J. Hines (Company Rep)

ID · 1df67e89-7f5b-42de-9273-2767b9fe60d6

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1009887
FDA center
Human Drugs
Project area
Bioresearch Monitoring
Outcome
Form 483 issued

FDA Citations

1
  1. 21 CFR 312.62(b)Case history records- inadequate or inadequate

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Joseph L. Lillo, D.O.

4
DateClassificationOfficeProject area
March 22, 2021VAICenter for Drug Evaluation and ResearchBioresearch Monitoring
December 9, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
April 12, 2017VAICenter for Drug Evaluation and ResearchBioresearch Monitoring
February 26, 2014NAICenter for Drug Evaluation and ResearchBioresearch Monitoring

Other documents for Joseph L. Lillo, D.O.

4
Document
FDA Inspection 1136939 · March 22, 2021 
FDA Inspection 1112185 · December 9, 2019 
FDA Inspection 1009886 · April 12, 2017 
FDA Inspection 866757 · February 26, 2014 
View Company ProfileHave an account? Sign in to open in Dashboard

Or discuss it with

What you get

  1. A document

    One file.

    • One FDA document, such as a Form 483
    • Yours for life in your Library
    • Each has its own price
    here
  2. The profile

    All the documents, plus intelligence about the company.

    • Every Joseph L. Lillo, D.O. document on file
    • The KRA score, which a single document does not include
    • Observations and inspection history
  3. Access

    This, for every company on KeyPedia.

    • Combine profiles in one search
    • Search across any modality: products, industry types, drugs, devices and recalls
    • Track everything as it changes
    • Other agencies too, such as EMA, Health Canada and UK MHRA
    Browse free in KeyPedia Lite
KeyPedia
The intelligence layer for life sciences
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
Quick Links
HomePlatformUse CasesHardwarePricingResearchOur TechnologyFAQMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPrograms & Partnerships
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.